Insider Transactions in Q2 2022 at Nova Bay Pharmaceuticals, Inc. (NBY)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2022
|
Swan Sit Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Paul E. Freiman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Yenyou Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Mijia Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|